Also from this source

You just read:

CMS Issues Proposed National Coverage Determination of NGS IVDs Including Thermo Fisher Scientific's Oncomine Dx Target Test

News provided by

Thermo Fisher Scientific Inc.

Dec 07, 2017, 06:30 EST